-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SVQNuXf8Sf3ZBhh3f4nWgb+FJs3oYzKjmkJJlgGlgz55sDp6m350t0g/bVipRaTK or/Mu3ans5V5ilrj6LGI1g== 0000950162-99-001142.txt : 19991130 0000950162-99-001142.hdr.sgml : 19991130 ACCESSION NUMBER: 0000950162-99-001142 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19991129 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-43408 FILM NUMBER: 99765423 BUSINESS ADDRESS: STREET 1: 901 MARINERS ISLAND BLVD STREET 2: SUITE 315 CITY: SAN MATEO STATE: CA ZIP: 94404 BUSINESS PHONE: 6503583456 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SIGMA TAU FINANZIARIA CENTRAL INDEX KEY: 0001092601 STANDARD INDUSTRIAL CLASSIFICATION: [] FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: VIA SUDAFRICA 20 STREET 2: 00144 CITY: ROME ITALY MAIL ADDRESS: STREET 1: VIA SUDAFRICA 20 STREET 2: 00144 CITY: ROME ITALY SC 13G/A 1 SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Amendment No. 1 Under the Securities Exchange Act of 1934 SciClone Pharmaceuticals, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, No Par Value - -------------------------------------------------------------------------------- (Title of Class of Securities) 80862K104 - -------------------------------------------------------------------------------- (CUSIP Number) November 18, 1999 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: / / Rule 13d-1(b) /X/ Rule 13d-1(c) / / Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). -2- - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Aptafin SpA - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) / / (b) / / - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Italy - -------------------------------------------------------------------------------- 5. Sole Voting Power 360,500 ----------------------------------------------------- Number of 6. Shared Voting Power Shares Beneficially 909,500 ----------------------------------------------------- Owned by Each 7. Sole Dispositive Power Reporting Person With: 360,500 ----------------------------------------------------- 8. Shared Dispositive Power 909,500 - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,270,000 - -------------------------------------------------------------------------------- 10. Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) / / - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (9) 5.10% - -------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) CO -3- - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Sigma-Tau Finanziaria SpA - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) / / (b) / / - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Italy - -------------------------------------------------------------------------------- 5. Sole Voting Power 909,500 ----------------------------------------------------- Number of 6. Shared Voting Power Shares Beneficially 0 ----------------------------------------------------- Owned by Each 7. Sole Dispositive Power Reporting Person With: 909,500 ----------------------------------------------------- 8. Shared Dispositive Power 0 - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 909,500 - -------------------------------------------------------------------------------- 10. Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) / / - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (9) 3.65% - -------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) CO -4- Item 1(a). Name of Issuer: SciClone Pharmaceuticals, Inc. Item 1(b). Address of Issuer's Principal Executive Offices: 901 Mariner's Island Boulevard, Suite 315, San Mateo, CA 94404 Item 2(a). Name of Person Filing: This statement is filed on behalf of each of the following persons (collectively, the "Reporting Persons") (i) Aptafin SpA ("Aptafin"), (2) Sigma-Tau Finanziaria SpA ("Sigma-Tau") Item 2(b). Address of Principal Business Office: (1) Aptafin Via Santissimi Pietro e Paolo, 30 00144 Rome Italy (2) Sigma-Tau Via Sudafrica, 20 00144 Rome Italy Item 2(c). Citizenship: (1) Aptafin is an Italian corporation. (2) Sigma-Tau is an Italian corporation. Item 2(d). Title of Class of Securities: Common Stock, no par value (the "Shares") Item 2(e). CUSIP Number: 80862K104 Item 3. If this statement is filed pursuant to ss.ss.240.13d-1(b) or 240.13d-2(b) or (c), check whether the person is a: This Item 3 is not applicable -5- Item 4. Ownership: Aptafin (a) Amount beneficially owned: 1,270,000 (b) Percent of class: 5.10% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 360,500 (ii) shared power to vote or to direct the vote: 909,500 (iii) sole power to dispose or to direct the disposition of: 360,500 (iv) shared power to dispose or to direct the disposition of: 909,500 Sigma-Tau (a) Amount beneficially owned: 909,500 (b) Percent of class: 3.65% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 909,500 (1) (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 909,500 (1) (iv) shared power to dispose or to direct the disposition of: 0 --------- (1): 445,000 of the Shares held by Sigma Tau are restricted shares and are subject to certain limitations on resale. Item 5. Ownership of Five Percent or Less of a Class: Not Applicable Item 6. Ownership of More than Five Percent on Behalf of Another Person: Not Applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company: Not Applicable Item 8. Identification and Classification of Members of the Group: Not Applicable Item 9. Notice of Dissolution of Group: Not Applicable Item 10. Certification: -6- By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. -7- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: November 17, 1999 APTAFIN SPA By: /s/ Piero Belletti ------------------------------------- Name: Piero Belletti Title: Managing Director Dated: November 17, 1999 SIGMA TAU FINANZIARIA SPA By: /s/ Paolo Cavazza ------------------------------------- Name: Paolo Cavazza Title: Vice President and Managing Director -8- EXHIBIT INDEX Page No. A. Joint Filing Agreement dated November 17, 1999 by and among Aptafin SpA and Sigma Tau Finanziaria SpA................................................... 9 -9- EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of SciClone Pharmaceuticals, Inc. dated as of November 18, 1999 is, and any amendments thereto (including amendments on each of us pursuant to and in accordance with the provisions of Rule 13d-1(f) under the Securities Exchange Act of 1934). Dated: November 17, 1999 APTAFIN SPA By: /s/ Piero Belletti ------------------------------------ Name: Piero Belletti Title: Managing Director SIGMA TAU FINANZIARIA SPA Dated: November 17, 1999 By: /s/ Paolo Cavazza ------------------------------------ Name: Paolo Cavazza Title: Vice President and Managing Director -----END PRIVACY-ENHANCED MESSAGE-----